Cancer Genetics and Epigenetics, 2025, Vol.13, No.6, 287-299 http://medscipublisher.com/index.php/cge 299 Slater S., Bryant A., Aresu M., Begum R., Chen H., Peckitt C., Lazaro-Alcausi R., Carter P., Anandappa G., Khakoo S., Melcher L., Potter V., Marti F., Huang J., Branagan G., George N., Abulafi M., Duff S., Raja A., Gupta A., West N., Bucheit L., Rich T., Chau I., Cunningham D., and Starling N., 2024, Tissue-free liquid biopsies combining genomic and methylation signals for minimal residual disease detection in patients with early colorectal cancer from the UK TRACC Part B study, Clinical Cancer Research, 30: 3459-3469. https://doi.org/10.1158/1078-0432.ccr-24-0226 Taïeb J., Sullo F., Lecanu A., Bourreau C., Barbier E., Gandini A., Bez J., Mulot C., Di Fiore F., Elhajbi F., Borg C., BouchéO., Aparicio T., Zaanan A., André T., Tougeron D., Taly V., and Laurent-Puig P., 2025, Early ctDNA and survival in metastatic colorectal cancer treated with immune checkpoint inhibitors: a secondary analysis of the SAMCO-PRODIGE 54 randomized clinical trial, JAMA Oncology, 18: e251646. Takagi M., Kim S., Suzuki M., Takayama T., and Asano H., 2025, Factors associated with postoperative recurrence in perforated colorectal cancer: unraveling the high recurrence rate of perforated colorectal cancer, World Journal of Surgical Oncology, 23(1): 139. https://doi.org/10.1186/s12957-025-03783-5 Tang J., Zhang Y., Ji D., Wang L., Zhuo H., Wang Y., and Sun Y., 2025, Somatic mutation correlation with lymph node metastasis and prognosis in T1/2 stage colorectal cancer patients: a propensity score matching analysis, Clinical and Translational Medicine, 15(1): e70179. https://doi.org/10.1002/ctm2.70179 Tie J., Cohen J., Wang Y., Ginestet P., Wong R., Shapiro J., Campbell R., Day F., Hayes T., Aghmesheh M., Karapetis C., Popoli M., Dobbyn L., Ptak J., Silliman N., Douville C., Papadopoulos N., Kinzler K., Vogelstein B., and Gibbs P., 2024, Circulating tumor DNA analysis informing adjuvant chemotherapy in locally advanced rectal cancer: the randomized AGITG DYNAMIC-Rectal study, Journal of Clinical Oncology, 42(3_supp1): 12. https://doi.org/10.1200/jco.2024.42.3_suppl.12 Tie J., Wang Y., Loree J., Cohen J., Espinosa D., Wong R., Price T., Tebbutt N., Lee M., Burge M., Harris S., Lee B., Lynam J., O'Callaghan C., Breadner D., Bettegowda C., Papadopoulos N., Kinzler K., Vogelstein B., and Gibbs P., 2025, ctDNA-guided adjuvant chemotherapy escalation in stage III colon cancer: Primary analysis of the ctDNA-positive cohort from the randomized AGITG dynamic-III trial (intergroup study of AGITG and CCTG), Journal of Clinical Oncology, 43(16_suppl): 3503. https://doi.org/10.1200/jco.2025.43.16_suppl.3503 Van Steijn D., Laliotis G., Spickard E., Schraa S., Van Der Baan F., Punt C., Van Den Broek D., Sharma S., Sethi H., Liu M., Jurdi A., Kok N., Koopman M., Vink G., and Fijneman R., 2025, Longitudinal ctDNA measurements for treatment response monitoring in patients with metastatic colorectal cancer undergoing systemic therapy: the ORCA trial, Journal of Clinical Oncology, 43(4_supp1): 220. https://doi.org/10.1200/jco.2025.43.4_suppl.220 Van Steijn D., Medina J., Rinaldi L., Closa A., Meiqari L., Peters E., Konicki A., Van Der Baan F., Bierkens M., Wang H., Greuter M., Lissenberg-Witte B., CoupéV., Coignet M., Velculescu V., Van Den Broek D., Meijer G., Lahaye M., Braat M., Roodhart J., Dracopoli N., Vink G., Kok N., and Fijneman R., 2025, Abstract 3241: cell-free DNA fragmentomes for treatment response monitoring in patients with metastatic colorectal cancer: the DOLPHIN study, Cancer Research, 85(8_Supplement_1): 3241. Xu D., Bao Q., Wang H., Jin K., Liu M., Liu W., Yan X., Wang L., Wang Y., Li J., Zhao T., Zhang J., Zhang D., Wang K., and Xing B., 2025, Dynamic CtDNA monitoring in adjuvant therapy and recurrence for colorectal liver metastases: a prospective study, International Journal of Surgery, 111(7): 4464-4475. https://doi.org/10.1097/js9.0000000000002504 Zhang X., Cao D., Du J., Hu R., Cai X., Wu T., Yu K., Zhang Y., Xia C., Wang Y., Yang Q., and Li Y., 2025, The efficacy of watch and wait strategy or surgery after neoadjuvant immunotherapy for locally advanced colorectal cancer with dMMR/MSI-H guided by ctDNA dynamic monitoring (WINDOW): a single-center open-label prospective phase II study, Journal of Clinical Oncology, 43(16_suppl): 3559. https://doi.org/10.1200/jco.2025.43.16_suppl.3559 Zhou J., Huang J., Zhou Z., Fan R., Deng X., Qiu M., Wu Q., and Wang Z., 2025, Value of ctDNA in surveillance of adjuvant chemosensitivity and regimen adjustment in stage III colon cancer: a protocol for phase II multicentre randomised controlled trial (REVISE trial, BMJ Open, 15(1): e090394. https://doi.org/10.1136/bmjopen-2024-090394
RkJQdWJsaXNoZXIy MjQ4ODYzNA==